Status:
COMPLETED
Performance of CT Parameters Compared to Bone Mineral Density to Detect Bone Fragility in Rheumatoid Arthritis
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Osteoporosis
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Objective: To evaluate the performance of CT parameters (SBAC-L1 and fractal analysis) compared to BMD (gold standard) to detect vertebral fractures in rheumatoid arthritis
Detailed Description
To evaluate the performance of scanographic bone attenuation coefficient of the first lumbar vertebra (SBAC-L1) and fractal analysis, markers of bone fragility on computed tomography (CT), compared to...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Rheumatoid arthritis patients followed from 2009 to 2019 in Nancy University hospital who met the 2010 ACR/EULAR criteria for RA
- Thoraco-abdomino-pelvic CT (TAP-CT) and BMD (spine, hip) within a period of up to 2 years
Exclusion
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT04413448
Start Date
January 1 2020
End Date
January 1 2020
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Nancy
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France, 54511